(Q61651734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

A humanized monovalent CD3 antibody which can activate homologous complement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Herman Waldmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

Routledge EG

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Lloyd I

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Gorman SD

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

language of work or name

English

0 references

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

19 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

2717-2725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

A new subunit of the human T-cell antigen receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Structure of the T cell antigen receptor (TCR): two CD3 epsilon subunits in a functional TCR/CD3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

In vivo administration of anti-CD3 prevents malignant progressor tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Hybrid antibodies can target sites for attack by T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

A rat model for imaging the effect of anti mouse antibody responses on the biodistribution of radiolabelled mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Reshaping human antibodies: grafting an antilysozyme activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Therapeutic potential of monovalent monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

The immunoglobulin lambda locus in rat consists of two C lambda genes and a single V lambda gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Structure of human immunoglobulin gamma genes: implications for evolution of a gene family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Univalent antibodies kill tumour cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Sequences of mouse immunoglobulin light chain genes before and after somatic changes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Reshaping a therapeutic CD4 antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

A humanized antibody that binds to the interleukin 2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Monoclonal-Antibody Therapy in Systemic Vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

The immunogenicity of chimeric antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Correlation between segmental flexibility and effector function of antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Efficiency of activation of complement by anti-hapten antibodies at the red cell surface: effect of patchy vs random distribution of hapten.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830211111

7 January 2021

Identifiers

DOI

10.1002/EJI.1830211111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1834468%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference